Drug information for ATAZANAVIR SULFATE AND RITONAVIR
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL
300MG/100MG
Tentative Approval
ATAZANAVIR SULFATE
;
RITONAVIR
atazanavir
MATRIX LABS LTD
22282
2011-12-07 Letter
Drug Adverse Effects information for ATAZANAVIR SULFATE AND RITONAVIR
Role code
Indications
Reaction
# Reports
SS
ANTIVIRAL TREATMENT
ASCITES
22
SS
ANTIVIRAL TREATMENT
CHOLESTASIS
22
SS
ANTIVIRAL TREATMENT
HAEMATOTOXICITY
22
SS
ANTIVIRAL TREATMENT
HYPOPHOSPHATAEMIA
22
SS
ANTIVIRAL TREATMENT
IRON DEFICIENCY ANAEMIA
22
SS
ANTIVIRAL TREATMENT
LIPOATROPHY
22
SS
ANTIVIRAL TREATMENT
LIVER DISORDER
22
SS
ANTIVIRAL TREATMENT
OESOPHAGEAL VARICES HAEMORRHAGE
22
SS
ANTIVIRAL TREATMENT
PORTAL HYPERTENSION
22
SS
ANTIVIRAL TREATMENT
PORTAL VEIN THROMBOSIS
22
SS
ANTIVIRAL TREATMENT
PROTEINURIA
22
SS
ANTIVIRAL TREATMENT
SPLENOMEGALY
22
SS
ANTIVIRAL TREATMENT
TRANSAMINASES INCREASED
22
SS
ANTIVIRAL TREATMENT
VIROLOGIC FAILURE
22
SS
HIV INFECTION
CHRONIC HEPATITIS
4
SS
HIV INFECTION
HEPATIC ENZYME INCREASED
4
Ads by Google